Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2009-12-22 Annual Report
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 10-K
Annual Report FY 2009
2009-12-22 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement offering of equity securities, including details about the units sold, pricing, warrants, and regulatory exemptions. This is an update on the company's financing activities, specifically a capital raise through a private placement. The document is not a full financial report, earnings release, or management discussion, but rather a disclosure of a financing transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4010 characters, which is typical for an 8-K filing of this nature and not a report publication announcement or regulatory filing fallback. Confidence is high given the clear description of a financing event.
2009-12-17 English
STOCK TRANSFER
Director's Dealing
2009-11-12 English
E. FRYKMAN STOCK OPTION GRANT 10/2009
Director's Dealing
2009-10-13 English
L. RAHN STOCK OPTION GRANT 10/2009
Director's Dealing
2009-10-13 English
C. MCKENNEY STOCK OPTION GRANT 10/2009
Director's Dealing
2009-10-13 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.